Skip to main content
Equibles

Fisher Asset Management, LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 850529 PLANO, TX
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$17,690,519
+$1,376,789 QoQ
Shares Held
699,230
-4.6% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 354 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 39% Shared 0% None 61%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Fisher Asset Management, LLC holds $807,507,065 across 59 Biotechnology names. ACAD ranks #17 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARWR
Arrowhead Pharmaceuticals, Inc.
 957,691 $78,061,393
2 RCUS
Arcus Biosciences, Inc.
 2,139,396 $65,957,578
3 CYTK
Cytokinetics Inc
 743,697 $63,355,547
4 DNLI
Denali Therapeutics Inc.
 2,414,162 $62,092,246
5 RVMD
Revolution Medicines, Inc.
 207,693 $38,896,745
6 LGND
Ligand Pharmaceuticals Inc
 121,440 $38,385,969
7 CLDX
Celldex Therapeutics, Inc.
 985,677 $36,677,041
8 HALO
Halozyme Therapeutics, Inc.
 427,713 $33,477,096

All Filings in ACAD

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,690,519 699,230
2026-03-31 $16,313,730 732,872
2025-12-31 $17,764,473 665,087
2025-09-30 $13,625,419 638,492
2025-06-30 $6,693,408 310,311
2025-03-31 $5,896,898 355,021
2024-12-31 $6,009,716 327,505
2024-09-30 $2,992,932 194,599
2024-06-30 $2,642,558 162,619
2024-03-31 $2,827,675 152,930
2023-12-31 $4,479,020 143,054